Perjeta (Pertuzumab Injection)

Perjeta (Pertuzumab Injection)

Brand: Roche
Product Code: PSAM6891445
Availability: In Stock
Price: $11,993.00
Qty:
    - OR -   Add to Wish List
Add to Compare

Perjeta (Pertuzumab Injection)

Perjeta (Pertuzumab Injection) is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

 

 Perjeta (Pertuzumab Injection) usage

Perjeta (Pertuzumab Injection) is a HER2/neu receptor antagonist indicated for:

    Use in combination with trastuzumab and docetaxel for treatment of patients with HER2-positive metastatic breast cancer (MBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

    Use in combination with trastuzumab and docetaxel as neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than 2 cm in diameter or node positive) as part of a complete treatment regimen for early breast cancer. This indication is based on demonstration of an improvement in pathological complete response rate. No data are available demonstrating improvement in event-free survival or overall survival.

 

Limitations of Use: :

    The safety of Perjeta (Pertuzumab Injection) as part of a doxorubicin-containing regimen has not been established.

    The safety of Perjeta (Pertuzumab Injection) administered for greater than 6 cycles for early breast cancer has not been established. .

Write a review

Your Name:


Your Review: Note: HTML is not translated!

Rating: Bad           Good

Enter the code in the box below:



Powered By pshealth
Pharmacyanddrug © 2017.
paymethods